Insider Cluster (2 insiders) ·Filed Jul 21, 2026

DXCM

DEXCOM INC
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $2.2M total
Actionable Insight • Neutral

This cluster is too small relative to market cap to warrant a trading signal. Monitor for any material corporate events (earnings, product announcements, regulatory decisions) that could explain the sales, but the dollar amounts are consistent with routine portfolio diversification or tax planning.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
DXCM ▲ +25.69% at T+20d
NEUTRAL call ✓ call won +25.69% · α vs SPY +22.80% · entry $71.43 → $89.78
Next anchor: T+60d in 12d
Latest observation: T+48 +4.94% FF3 residual α
Entry anchored
Jul 21, 03:59 PM ET
via exchange tick
T+1d
-1.33%
call -1.33% · α -0.10%
$70.48
settled 2mo ago
T+5d
+5.19%
call +5.19% · α +7.60%
$75.14
settled 2mo ago
T+20d
+25.69%
call +25.69% · α +22.80%
$89.78
settled 6w ago
T+60d
—
call — · α —
—
in 12d

Price Chart

Loading chart...

Executive Summary

Two DexCom insiders, including Executive Chair Kevin Sayer, sold a combined $2.17M in open-market sales over a 7-day window. The total value is only ~0.007% of DexCom's $29.2B market cap, making this a trivial cluster by proportionality standards. Insider sales are weak predictors on average, and this cluster does not carry material informational content.

Key Financial Metrics

Direction
selling
Total Value
$2.2M
Insiders
2

Key Facts

  • Executive Chair Kevin Sayer sold 26,756 shares for $2.04M on 2026-07-20
  • EVP & Chief Legal & Compliance Officer Michael Brown sold 1,700 shares for $127K on 2026-07-15
  • Total cluster value of $2.17M is only ~0.007% of DexCom's $29.2B market cap
  • Both sales were open-market transactions (code S)
  • No insider buying activity in the cluster window

Financial Impact

$2.17M in total insider sales, representing ~0.007% of market cap

Risk Factors

  • Insider sales are weak predictors of future returns, especially at this trivial scale
  • No contextual filings (earnings, M&A, regulatory) were provided to explain the sales

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
87% bullish (38 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DXCM-1784667690960
11 reports for DXCM
Performance horizon
Filters
Rows
Reports for DXCM — sortable, filterable
TypeNow
Sep 14, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$86.45 $89.53▲ +3.56%▲ +1.44%$85.68 (−0.90%)
Aug 28, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $84.53▼ −7.17%▼ −7.03%$85.68 (−5.91%)
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $91.06· 0.00%▼ −0.47%$85.68 (−5.91%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$88.76 $91.06▲ +2.59%▲ +3.78%$85.68 (−3.47%)
Jul 21, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.43 $75.14▲ +5.19%▲ +7.60%$85.68 (+19.94%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$72.47 $68.65▼ −5.27%▼ −3.61%$85.68 (+18.22%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$70.17 $73.45▲ +4.67%▲ +3.46%$85.68 (+22.09%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$70.17 $72.70▲ +3.61%▲ +3.14%$85.68 (+22.09%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.24 $72.27▲ +1.45%▼ −0.36%$85.68 (+20.26%)
Apr 15, 2026
24w ago
DEFA14A
NEUTRAL ★ 2/10
$61.01 $62.68▲ +2.74%▲ +1.75%$85.68 (+40.42%)
Showing 10 of 11

US Market Status

Market Open — Closes in 6h 25m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 21, 2026